Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study [v1; ref status: indexed, http://f1000r.es/34l]

by Sreeram Ramagopalan, Andrew P. Skingsley, Lahiru Handunnetthi, Michelle Klingel, Daniel Magnus, Julia Pakpoor, Ben Goldacre
Published 2014-03-01

An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis.

by Adam E Handel, Alexander J Williamson, Giulio Disanto, Lahiru Handunnetthi, Gavin Giovannoni, Sreeram V Ramagopalan
Published 2010-09-01

Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a c...

by Sreeram V Ramagopalan, Andrew P. Skingsley, Lahiru Handunnetthi, Daniel Magnus, Michelle Klingel, Julia Pakpoor, Ben Goldacre
Published 2015-04-01

The effect of single nucleotide polymorphisms from genome wide association studies in multiple sclerosis on gene expression.

by Adam E Handel, Lahiru Handunnetthi, Antonio J Berlanga, Corey T Watson, Julia M Morahan, Sreeram V Ramagopalan
Published 2010-04-01

Heterogeneity in Multiple Sclerosis: Scratching the Surface of a Complex Disease

by Giulio Disanto, Antonio J. Berlanga, Adam E. Handel, Andrea E. Para, Amy M. Burrell, Anastasia Fries, Lahiru Handunnetthi, Gabriele C. De Luca, Julia M. Morahan
Published 2011-01-01

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

by Sreeram V Ramagopalan, Narelle J Maugeri, Lahiru Handunnetthi, Matthew R Lincoln, Sarah-Michelle Orton, David A Dyment, Gabriele C Deluca, Blanca M Herrera, Michael J Chao, A Dessa Sadovnick, George C Ebers, Julian C Knight
Published 2009-02-01